In this video, Motley Fool health-care bureau chief Brenton Flynn takes a look through some recent SEC filings where investors don't often look for information, to discover some of the less-reported information on some of the biggest names in the health-care investments sector today. He discusses Abbott Labs (NYSE: ABT) and its coming spinoff AbbVie, a new indication for Questcor (NASDAQ: QCOR), a savvy sell by Dendreon (NASDAQ: DNDN), general pessimism about the economic climate from Express Scripts (NASDAQ: ESRX), and some uncertainty from MAKO Surgical (NASDAQ:MAKO) in the wake of Hurricane Sandy.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.